Replies to post #1551 on Galectin Therapeutics Inc. (GALT)

[BelizeBeachTrader]

Interim results for Cohort3 are expected along with Cohort1 & 2 presentation. I think we will have to wait until the end of Nov. for the complete report on Cohort3.


http://www.marketwatch.com/story/galectin-therapeutics-abstract-accepted-as-oral-presentation-at-the-liver-meetingr-annual-meeting-of-the-american-association-for-the-study-of-liver-diseases-2014-10-01